Involvement of prostaglandins in an animal model of Shigella-related seizures

Yael Yuhas, Abraham Weizman, Alexey Vanichkin, Shai Ashkenazi

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


We investigated whether prostaglandins (PGs), proinflammatory mediators implicated in excitatory activity, are involved in Shigella-related seizures. Pretreatment with S. dysenteriae sonicate (2LD50) enhanced mice response to pentylenetetrazole-induced seizures, without increase of brain concentrations of PGE2, PGD2 or PGF. Preinjection of NS-398, an inhibitor of cyclooxygenase-2, before treatment with Shigella sonicate, had no effect on seizures. The anticonvulsive PGD2 increased after injection of 8 LD50 of Shigella sonicate, which did not enhance seizures (32 pg/mg vs 26 pg/ml, p = 0.0063). The findings indicate that PGs are not involved in the enhanced seizure response after exposure to Shigella. However, induction of PGD2 may play an inhibitory role.

Original languageEnglish
Pages (from-to)34-39
Number of pages6
JournalJournal of Neuroimmunology
Issue number1-2
StatePublished - Nov 2005
Externally publishedYes


  • Animal model
  • Prostaglandins
  • Seizures
  • Shigella


Dive into the research topics of 'Involvement of prostaglandins in an animal model of Shigella-related seizures'. Together they form a unique fingerprint.

Cite this